Head and Neck Diseases by Alexandros G.Sfakianakis: Natalizumab Changes the Peripheral Profile of the Th17 Panel in MS Patients: New Mechanisms of Action

Σάββατο 17 Μαρτίου 2018

Natalizumab Changes the Peripheral Profile of the Th17 Panel in MS Patients: New Mechanisms of Action

http://ift.tt/2IxXPix

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου